Results 41 to 50 of about 21,895 (224)

Mortality of bullous pemphigoid in Switzerland: a prospective study

open access: yes, 2011
Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and has been associated with a significant morbidity and an increased mortality ...
Combescure, C   +5 more
core   +1 more source

Correlation between bullous pemphigoid and type 2 inflammation

open access: yesPifu-xingbing zhenliaoxue zazhi, 2022
Bullous pemphigoid (BP) is one of the common autoimmune blister diseases that mainly affects the elderly. Most bullous pemphigoid patients have obvious symptom of pruritus, accompanied by elevated levels of serum total IgE, peripheral blood eosinophils ...
Yao ZHOU   +6 more
doaj   +1 more source

Bullous Pemphigoid Complicated by Sepsis

open access: yes, 2022
Patients with bullous pemphigoid face many challenges when managing their disorder, one of which is balancing medication with their ailments. Because the patient population with bullous pemphigoid are primarily elderly, the current first-line treatment ...
Falgiani, Michael   +4 more
core   +1 more source

Lower Extremity Salvage in the Setting of Bullous Pemphigoid Exacerbation: A Case Report

open access: yesPlastic and Reconstructive Surgery, Global Open, 2021
Summary:. Bullous pemphigoid is an autoimmune blistering disease where patients suffer from painful bullae, often covering large portions of the skin and requiring management with immune-suppression.
Samara E. Pollock, MD   +5 more
doaj   +1 more source

A Systematic Review of Drug-Induced Pemphigoid

open access: yesActa Dermato-Venereologica, 2020
Bullous pemphigoid is an autoimmune subepithelial disease characterised by pruritus followed by urticarial plaques and finally bullae on the skin and mucosa.
Matthew J. Verheyden   +2 more
doaj   +1 more source

Safety outcomes of antidiabetic medications: A comprehensive review of the EU summaries of product characteristics and international clinical practice guidelines

open access: yesBritish Journal of Clinical Pharmacology, EarlyView.
Aims Information on the safety profile of antidiabetic medications is essential for informed treatment decisions in type 2 diabetes mellitus. Although this information is available in regulatory documents of individual drugs, a comprehensive overview across all approved antidiabetics is lacking.
David Liang   +5 more
wiley   +1 more source

Bullous pemphigoid: therapeutic algrorithm and practical management [PDF]

open access: yes, 2013
Introduction: Bullous pemphigoid (BP) is the most common autoimmune subepidermal blistering disease of the skin and mucosae. BP typically affects the elderly and manifests with severe itch, localised or generalised eczematous, urticated and/or bullous ...
Borradori, Luca   +2 more
core   +1 more source

A case report of bullous pemphigoid following secukinumab therapy for a patient with psoriasis

open access: yesJournal of Dermatological Treatment
Aim: Bullous pemphigoid induced by secukinumab in treatment of psoriasis is rare.Methods: We report a 49-year-old man with psoriasis who developed bullous pemphigoid during treatment with secukinumab.Results: Scattered tense vesicles with itching ...
Guanghan Wang   +3 more
doaj   +1 more source

Clinical Relevance of Autoantibodies in Patients with Autoimmune Bullous Dermatosis

open access: yesClinical and Developmental Immunology, 2012
The authors present their experience related to the diagnosis, treatment, and followup of 431 patients with bullous pemphigoid, 14 patients with juvenile bullous pemphigoid, and 273 patients with pemphigus.
Lilla Mihályi   +4 more
doaj   +1 more source

Pemphigoid gestationis and intravenous immunoglobulin therapy

open access: yesInternational Journal of Women's Dermatology, 2018
Pemphigoid gestationis, which is also known as herpes gestationis, is a rare, pregnancy-associated, autoimmune bullous disease. Treatment depends on the severity of the disease for each patient and the safety and use of these drugs during pregnancy and ...
Anes Yang, MD, BMed, MPH   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy